SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-328952
Filing Date
2021-11-15
Accepted
2021-11-15 07:46:07
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d400332d8k.htm   iXBRL 8-K 25958
2 EX-99.1 d400332dex991.htm EX-99.1 183302
  Complete submission text file 0001193125-21-328952.txt   392864

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dna-20211115.xsd EX-101.SCH 3959
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dna-20211115_def.xml EX-101.DEF 14211
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dna-20211115_lab.xml EX-101.LAB 23474
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dna-20211115_pre.xml EX-101.PRE 15244
7 EXTRACTED XBRL INSTANCE DOCUMENT d400332d8k_htm.xml XML 5422
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 211406377
SIC: 2836 Biological Products, (No Diagnostic Substances)